StartupsBasicBionyra Pharma Secures, 143 Million to Scale Inflammatory Disease Biologics
Paris and Boston-based Bionyra Pharma has officially launched with a significant, 143 million Series A funding round. The capital injection aims to accelerate the development of next-generation biologics targeting immune-mediated inflammatory conditions.
Published 2 hours ago
Read more →